|
Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour: A multicenter retrospective cohort study. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda |
Research Funding - Astellas Pharma; Bayer; BMS Oncology; Sanofi |
|
|
Consulting or Advisory Role - Veracyte |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Taris |
Honoraria - Aduro Biotech; Allergan (I); Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; Ferring; Janssen Oncology; Johnson & Johnson; Olympus; pacific edge; Pfizer; Photocure; Protara Therapeutics; QED Therapeutics |
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris |
Research Funding - Photocure |
Travel, Accommodations, Expenses - Janssen Oncology; Photocure |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - pacific edge; Urogen pharma |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - IPSEN, |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Intuitive Surgical |
|
|
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst) |
|
|
No Relationships to Disclose |
|
Christian Daniel Fankhauser |
No Relationships to Disclose |